MedTrace Logo

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

NCT06182657 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-02-08

No results posted yet for this study

Summary

This study aims to explore the prognostic value of pathological remission after one cycle of induction chemotherapy in locally advanced nasopharyngeal carcinoma, and the change of immune micro-environment after one cycle induction chemotherapy, including the density of immune cells infiltration and tertiary lymphoid structures.

Conditions

  • Nasopharyngeal Carcinoma
  • Pathologic Complete Response
  • Tumor Microenvironment

Sponsors & Collaborators

  • Jiangxi Provincial Cancer Hospital

    lead OTHER

Principal Investigators

  • Jingao Li, PhD · Jiangxi Provincial Cancer Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2027-06-30
Completion
2029-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06182657 on ClinicalTrials.gov